In-situ measurement of solid phase transformations during dissolution testing by Aaltonen, Jaakko et al.
In-situ Measurement of Solid Phase Transformations 
During Dissolution Testing
Jaakko Aaltonen1, 2, Leena Peltonen1, Jouni Hirvonen1, Clare Strachan2, Jukka Rantanen2, 3
1Division of Pharmaceutical Technology, University of Helsinki, Finland
2Drug Discovery and Development Technology Center, University of Helsinki, Finland
3Department of Pharmaceutics and Analytical Chemistry, The Danish University of Pharmaceutical Sciences
AIM
To combine in-situ solid phase analysis with 
intrinsic dissolution rate (IDR) measurements in 
order to achieve real-time molecular level
information of solid phase behavior of APIs 
during dissolution testing.
KEY FINDINGS
The solid phase behavior cannot always be 
reliably derived from the IDR curve. 
However, with in-situ solid phase analysis, 
direct information on possible solid phase 
changes can be obtained.
As a result, a deeper understanding of the 
phenomena related to overall dissolution is 
achieved.
INTRODUCTION
A solvent-mediated phase transformation from a 
metastable to a stable form can take place when 
a solid is in contact with a solvent, for example 
during dissolution testing. This can cause changes 
in solubility, dissolution rate and bioavailability. 
Traditionally, a change in the intrinsic dissolution 
rate (IDR) is linked to a solid phase 
transformation, but the information is not direct 
and can also be due to other factors. The purpose 
of this study was to apply in-situ solid-state 
analysis to IDR measurements, in order to get 
direct molecular level information of the reasons 
behind the dissolution rate changes. 
MODEL DRUGS
DISSOLUTION TESTING SET-UP
The dissolution tests were 
conducted with a channel flow 
intrinsic dissolution test 
apparatus in which only one 
surface of the powder 
compact is in contact with the 
dissolution medium. The 
compacts were placed in the 
sample holder, and Raman 
spectra were measured in situ




Scheme 1. The procedure: a solid sample is immersed in 
a liquid dissolution medium and both phases are 
analyzed simultaneously.
TECHNICAL DETAILS
The solid phase analysis was performed using 
Raman spectroscopy in situ during the IDR test, 
while the concentration of the drug in the 
dissolution medium was measured with a UV-Vis
spectrophotometer equipped with a flow-
through cuvette. The dissolution medium used in 
the study was purified water (t = 25 ºC, V = 500 
ml). (Scheme 1, Fig. 1). 
Raman spectra were standard normal variate
(SNV) corrected. Quantification of the solid forms 
was based on calibration curves constructed using 
anhydrate:monohydrate powder mixtures. 
Characteristic peaks for TP anhydrate, TP 
monohydrate, NF anhydrate and NF 
monohydrate were identified and a ratio of 
characteristic peak intensities was calculated for 
each calibration sample. Thereafter, the 
calculated ratios were correlated to the hydrate 
form contents of the samples.
CASE 3. IDR / SOLID PHASE ANALYSIS 
OF NITROFURANTOIN
CASE 2. IDR / SOLID PHASE ANALYSIS 
OF THEOPHYLLINE:MCC
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•TP anhydrate underwent a transformation to TP 
monohydrate during the dissolution test.
•The transformation started almost immediately 
after contact with the dissolution medium.
•The dissolution rate decreased as the amount of 
the stable hydrate form increased.
•An increase in the specific surface area was 
detected due to crystal growth of the 
monohydrate phase. Therefore, the dissolution 
rate of the transformed compact (initial 
anhydrate) was higher than that of initial 
monohydrate compact.
RESULTS
•The solid phase transformation was successfully 
measured in a mixture of an excipient and an API
•Presence of microcrystalline cellulose retarded 
the onset of the solid phase transformation, but 
MCC had no effect on the rate of transformation
RESULTS
•NF anhydrate (form β) transformed to NF 
monohydrate (form II) during the dissolution test.
•The solid phase transformation during 
dissolution involves several overlapping factors, 
and therefore no clear correlation with the 
dissolution rate and the solid phase composition 
was found.
•The dissolution rate changed many times during 
the test. Possible reasons include:
•Loose particles on the surface
•Specific surface area changes
•Wetting and dissolution of particles below 
the very surface
CASE 1. IDR / SOLID PHASE ANALYSIS 
OF THEOPHYLLINE
a) t=0 min: 
Only TP anhydrate 
crystals are  seen on 
the surface of the 
compact.
b) t=2 min:
Crystals of the 
monohydrate form 
nucleate and grow 
while both forms 
dissolve.
c) t=6 min:
No crystals of the 
anhydrate form are 
present on the 
surface anymore. 




Small crystals of NF 
anhydrate dissolve 
while crystals of the 
monohydrate form 
nucleate, grow and 
dissolve.
b) t=30 min:
Both forms dissolve 
and the fiber-like 




The whole surface is 
covered with the 
monohydrate form. 
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